Teleradiology Market

Executive Summary

Teleradiology Market was valued at US $7.19 billion in 2021 and is projected to grow at 16.00% CAGR over the forecast period to reach US $17.53 billion by 2027. Teleradiology Market represented US $1.85 billion opportunity over 2019-2021 and estimated to create US $10.33 billion opportunity in 2027 over 2021.

Teleradiology from Consainsights analyses the Teleradiology Market in the Life Sciences industry over the forecast period to 2027.

Teleradiology research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Teleradiology segmentation includes Product & Service, Imaging Technique, End User, Region and Geography.

Based on the Product & Service, the Teleradiology analysis covers Teleradiology Services, Software, Hardware.

In Product & Service segment, Teleradiology Services segment has highest cagr growth of 14.10%.

Based on the Imaging Technique, the Teleradiology analysis covers Computed Tomography, Magnetic Resonance Imaging, Ultrasound, X-Ray, Mammography, Nuclear Imaging, Fluoroscopy.

In Imaging Technique segment, Computed Tomography segment has highest cagr growth of 14.10%.

Based on the End User, the Teleradiology analysis covers Hospitals & Clinics, Diagnostic Imaging Centers & Laboratories, Long-Term Care Centers, Nursing Homes, & Assisted Living Facilities, Other End Users.

In End User segment, Hospitals & Clinics segment has highest cagr growth of 14.10%.

Based on the Region, the Teleradiology analysis covers North America, Europe, Asia Pacific, Latin America.

In Region segment, North America segment has highest cagr growth of 14.10%.

Based on the region, the Teleradiology analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Philips Healthcare, Mednax Services, Inc., Teleradiology Solutions, Carestream Health, Inc., Onrad, Inc., Usarad Holdings, Inc., Cerner Corporation, McKesson Corporation, Siemens Healthineers, Fujifilm Holdings Corporation, AGFA Healthcare, Ramsoft, Inc., Everlight Radiology, Novarad Corporation, Telediagnostic Solutions Pvt. Ltd., Statrad Llc, Medweb Llc, Nautilus Medical, Telerad Tech, Webrad Teleradiology and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product & Service

Introduction

In 2021, Teleradiology Services segment has the highest revenue of US $4.93 billion and is expected to grow at CAGR of 14.10% by 2027 Teleradiology Services segment has highest cagr growth of 14.10%.

Teleradiology Services

Teleradiology Services segment was valued at US $3.66 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $12.01 billion by 2027. Teleradiology Services segment represented US $1.27 billion opportunity over 2019-2021 and estimated to create US $7.08 billion opportunity in 2027 over 2021.

Software

Software segment was valued at US $1.30 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $4.25 billion by 2027. Software segment represented US $0.45 billion opportunity over 2019-2021 and estimated to create US $2.51 billion opportunity in 2027 over 2021.

Hardware

Hardware segment was valued at US $0.38 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $1.26 billion by 2027. Hardware segment represented US $0.13 billion opportunity over 2019-2021 and estimated to create US $0.74 billion opportunity in 2027 over 2021.

Imaging Technique

Introduction

In 2021, Computed Tomography segment has the highest revenue of US $2.80 billion and is expected to grow at CAGR of 14.10% by 2027 Computed Tomography segment has highest cagr growth of 14.10%.

Computed Tomography

Computed Tomography segment was valued at US $2.08 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $6.83 billion by 2027. Computed Tomography segment represented US $0.72 billion opportunity over 2019-2021 and estimated to create US $4.03 billion opportunity in 2027 over 2021.

Magnetic Resonance Imaging

Magnetic Resonance Imaging segment was valued at US $1.32 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $4.34 billion by 2027. Magnetic Resonance Imaging segment represented US $0.46 billion opportunity over 2019-2021 and estimated to create US $2.56 billion opportunity in 2027 over 2021.

Ultrasound

Ultrasound segment was valued at US $0.86 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $2.83 billion by 2027. Ultrasound segment represented US $0.30 billion opportunity over 2019-2021 and estimated to create US $1.67 billion opportunity in 2027 over 2021.

X-Ray

X-Ray segment was valued at US $0.44 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $1.44 billion by 2027. X-Ray segment represented US $0.15 billion opportunity over 2019-2021 and estimated to create US $0.85 billion opportunity in 2027 over 2021.

Mammography

Mammography segment was valued at US $0.39 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $1.29 billion by 2027. Mammography segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.76 billion opportunity in 2027 over 2021.

Nuclear Imaging

Nuclear Imaging segment was valued at US $0.11 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $0.36 billion by 2027. Nuclear Imaging segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.21 billion opportunity in 2027 over 2021.

Fluoroscopy

Fluoroscopy segment was valued at US $0.13 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $0.44 billion by 2027. Fluoroscopy segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.26 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals & Clinics segment has the highest revenue of US $4.00 billion and is expected to grow at CAGR of 14.10% by 2027 Hospitals & Clinics segment has highest cagr growth of 14.10%.

Hospitals & Clinics

Hospitals & Clinics segment was valued at US $2.97 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $9.75 billion by 2027. Hospitals & Clinics segment represented US $1.03 billion opportunity over 2019-2021 and estimated to create US $5.75 billion opportunity in 2027 over 2021.

Diagnostic Imaging Centers & Laboratories

Diagnostic Imaging Centers & Laboratories segment was valued at US $1.37 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $4.49 billion by 2027. Diagnostic Imaging Centers & Laboratories segment represented US $0.47 billion opportunity over 2019-2021 and estimated to create US $2.65 billion opportunity in 2027 over 2021.

Long-Term Care Centers, Nursing Homes, & Assisted Living Facilities

Long-Term Care Centers, Nursing Homes, & Assisted Living Facilities segment was valued at US $0.89 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $2.93 billion by 2027. Long-Term Care Centers, Nursing Homes, & Assisted Living Facilities segment represented US $0.31 billion opportunity over 2019-2021 and estimated to create US $1.73 billion opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $0.11 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $0.35 billion by 2027. Other End Users segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.21 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $3.06 billion and is expected to grow at CAGR of 14.10% by 2027 North America segment has highest cagr growth of 14.10%.

North America

North America segment was valued at US $2.27 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $7.44 billion by 2027. North America segment represented US $0.78 billion opportunity over 2019-2021 and estimated to create US $4.39 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $1.40 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $4.58 billion by 2027. Europe segment represented US $0.48 billion opportunity over 2019-2021 and estimated to create US $2.70 billion opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $0.72 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $2.36 billion by 2027. Asia Pacific segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $1.39 billion opportunity in 2027 over 2021.

Latin America

Latin America segment was valued at US $0.96 billion in 2019 and is projected to grow at 14.10% CAGR over the forecast period to reach US $3.15 billion by 2027. Latin America segment represented US $0.33 billion opportunity over 2019-2021 and estimated to create US $1.86 billion opportunity in 2027 over 2021.